Evidence map›Paper›PMID 40730228›Full record

ArticleNature2025

The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies.

Kyle Swanson, Wesley Wu, Nash L Bulaong, John E Pak, James Zou

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Review
  2. Unlocking Sensitive Data with SPHERE in the Age of AI.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. The rise of large language models and the direction and impact of US federal research funding.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kyle SwansonDepartment of Computer Science, Stanford University, Stanford, CA, USA.ORCID 0000-0002-7385-7844
Wesley WuChan Zuckerberg Biohub, San Francisco, CA, USA.ORCID 0000-0003-4594-0699
Nash L BulaongChan Zuckerberg Biohub, San Francisco, CA, USA.
John E PakChan Zuckerberg Biohub, San Francisco, CA, USA. john.pak@czbiohub.org.ORCID 0000-0002-2998-9735
James ZouDepartment of Computer Science, Stanford University, Stanford, CA, USA. jamesz@stanford.edu.ORCID 0000-0001-8880-4764

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Science frequently benefits from teams of interdisciplinary researchers

Indexed as

Artificial IntelligenceSARS-CoV-2Single-Domain AntibodiesUser-Computer InterfaceAntibodies, NeutralizingCOVID-19HumansModels, MolecularProtein FoldingSoftwareSpike Glycoprotein, CoronavirusAntibodies, NeutralizingSingle-Domain AntibodiesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.